Description

Carbamic Acid, [3-[(3-Chlorophenyl)Methyl]-3,4-Dihydro-4-Oxo-2-Propyl-6-Quinazolinyl]-, 1,1-Dimethylethyl Ester (9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its complex quinazolinone-based molecular structure. This compound is of significant value for its role as a key building block in the research and development of novel therapeutic agents, particularly in kinase inhibitor programs. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of targeted small-molecule drugs.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of potential drug candidates, especially kinase inhibitors targeting various disease pathways.
• Medicinal Chemistry Research: Used as a core scaffold or derivatization point for structure-activity relationship (SAR) studies in drug discovery projects.
• Biochemical Reagent: Serves as a tool compound or reference standard in biochemical assays to study enzyme inhibition and cellular signaling mechanisms.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for cGMP production of active pharmaceutical ingredients (APIs) under development.
• Academic Research: Utilized in university and institutional labs for fundamental research in organic synthesis and chemical biology.

Basic Information

Item	Details
Product Name	Carbamic Acid, [3-[(3-Chlorophenyl)Methyl]-3,4-Dihydro-4-Oxo-2-Propyl-6-Quinazolinyl]-, 1,1-Dimethylethyl Ester (9Ci)
CAS No.	579523-17-4
Molecular Formula	C24H26ClN3O3
Molecular Weight	439.94 g/mol
Synonyms	tert-Butyl N-[3-[(3-chlorophenyl)methyl]-4-oxo-2-propyl-3,4-dihydroquinazolin-6-yl]carbamate; 579523-17-4; Carbamic acid, N-[3-[(3-chlorophenyl)methyl]-4-oxo-2-propyl-3,4-dihydro-6-quinazolinyl]-, 1,1-dimethylethyl ester; 6-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-[(3-chlorophenyl)methyl]-2-propyl-4(3H)-quinazolinone
EINECS	Contact for details

Quality Control

Our production of Carbamic Acid, [3-[(3-Chlorophenyl)Methyl]-3,4-Dihydro-4-Oxo-2-Propyl-6-Quinazolinyl]-, 1,1-Dimethylethyl Ester (9Ci) adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided and can be tailored to meet specific client requirements for research or cGMP applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound is moisture-sensitive (hygroscopic); keep the container tightly sealed under an inert atmosphere if necessary to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.